España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vor Biopharma
VOR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.8900
-0.09
-8.84%
At close: -
$0.8804
-0.00960
-1.08%
After Hours: 4:57 PM EDT
Get Report
Comment
Vor Biopharma (VOR) Forecast
News
Earnings
Vor Biopharma (VOR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Vor Biopharma (NASDAQ:VOR) Stock
Vor Biopharma Stock (NASDAQ: VOR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 10, 2024
HC Wainwright & Co. Reiterates Buy on Vor Bio...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, December 09, 2024
Vor Biopharma shares are trading higher after...
Benzinga Newsdesk
Vor Bio Presents Data on AML Therapy at ASH 2...
Benzinga Newsdesk
Friday, November 08, 2024
Baird Maintains Outperform on Vor Biopharma, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Vor Bio...
Benzinga Newsdesk
Thursday, November 07, 2024
Vor Biopharma Q3 EPS $(0.40), Inline
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Vor Bio Has Appointed Han Choi As Its New Chi...
Benzinga Newsdesk
Tuesday, September 10, 2024
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, September 06, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Vor Bio...
Benzinga Newsdesk
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Vor Bio Releases New Clinical Data Confirming...
Benzinga Newsdesk
Thursday, September 05, 2024
Vor Bio shares are trading higher after the c...
Benzinga Newsdesk
Vor Bio New Clinical Data Validates Its Appro...
Benzinga Newsdesk
Wednesday, August 14, 2024
Barclays Maintains Overweight on Vor Biopharm...
Benzinga Newsdesk
Thursday, August 08, 2024
Vor Biopharma Q2 EPS $(0.41) Beats $(0.42) Es...
Benzinga Newsdesk
Monday, May 13, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Vor Biop...
Benzinga Newsdesk
Friday, May 10, 2024
Wedbush Reiterates Outperform on Vor Biopharm...
Benzinga Newsdesk
Thursday, May 09, 2024
Vor Biopharma Q1 2024 GAAP EPS $(0.45) Misses...
Benzinga Newsdesk
Tuesday, April 23, 2024
Wedbush Reiterates Outperform on Vor Biopharm...
Benzinga Newsdesk
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Friday, March 22, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, March 21, 2024
Stifel Maintains Buy on Vor Biopharma, Lowers...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Vor Biopharm...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Vor Biop...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Vor Bio...
Benzinga Newsdesk
Wednesday, March 20, 2024
Vor Biopharma: Q4 Earnings Insights
Benzinga Insights
Vor Biopharma Expects To Report Further Engra...
Benzinga Newsdesk
Vor Biopharma Q4 2023 GAAP EPS $(0.39) Beats ...
Benzinga Newsdesk
Thursday, January 18, 2024
Wedbush Reiterates Outperform on Vor Biopharm...
Benzinga Newsdesk
Wednesday, January 17, 2024
Vor Bio Doses First AML Patient With VCAR33
Benzinga Newsdesk
Thursday, November 09, 2023
Vor Bio Presents Data Update On Trem-cel At H...
Benzinga Newsdesk
Tuesday, November 07, 2023
Vor Biopharma Q3 EPS $(0.49) Misses $(0.47) E...
Benzinga Newsdesk
Thursday, November 02, 2023
Multiple Clinical And Preclinical Presentatio...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 14, 2023
The Latest Analyst Ratings for Vor Biopharma
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, August 11, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wedbush Maintains Outperform on Vor Biopharma...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Vor Bio...
Benzinga Newsdesk
Thursday, August 10, 2023
Vor Bio Reports Q2 2023 Cash, Cash Equivalent...
Benzinga Newsdesk
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, July 06, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch